Global Supply Chain Compliance, published by Baker McKenzie, focuses on legal and regulatory issues affecting international supply chains across various industries, including healthcare, life sciences, food, and manufacturing. The blog covers topics such as antitrust scrutiny, trade agreements, tariffs, compliance with labor and environmental regulations, intellectual property protection, and strategic partnerships. It addresses challenges posed by shifting trade policies, foreign ownership concerns, and operational risks in global supply chains. The content also explores opportunities for innovation, investment, and risk mitigation in supply chain management, emphasizing cross-border legal strategies and regulatory developments.
In brief
In July, we flagged the proposed new modern slavery offence. The Government has now released a consultation paper seeking written submissions regarding the design of the regime.
The proposed criminal “failure to prevent” offence would apply to…
On 13 July 2026, the European Commission adopted two measures to support implementation of the EU Deforestation Regulation (“EUDR”):
…
Regulation (EU) 2025/40 on packaging and packaging waste (“PPWR“) entered into force on 11 February 2025 and will apply progressively, with its main obligations becoming applicable from 12 August 2026. As businesses across the packaging value chain prepare for implementation,…
President Trump has issued an Executive Order (the Order) directing the Department of Justice (DOJ) and Federal Trade Commission (FTC) to launch investigations into the U.S. food sector, focusing on potential price-fixing, other forms of criminal collusion, and non-criminal anticompetitive…
Tariffs and shifting trade dynamics continue to disrupt healthcare and life sciences supply chains. But in addition to affecting operational and commercial outlooks for business, they are also revealing new opportunities for innovators and investors.
In the final article of…
As supply chains shift and vendor arrangements evolve in response to tariffs, life sciences companies must adapt to increasingly intricate and intertwined challenges across operational and commercial needs.
Manufacturing relocation, technology adoption, and new vendor partnerships require careful oversight of…
Following 16 years of negotiations, the Trade and Economic Partnership Agreement (TEPA) between India and the EFTA (European Free Trade Association) States – Switzerland, Iceland, Norway, and Liechtenstein – will enter into force on 1 October 2025. As the first…
Amid fluctuating tariffs and complex trade policies, healthcare and life sciences (HLS) companies face mounting operational and legal challenges within their global supply chains. Organizations are taking steps to retool their supply chains in response to threats against stability, but…
The healthcare and life sciences sector is facing new trade winds and a looming threat of increased tariffs. This places additional pressure on a typical life sciences supply chain timeline.
We recently launched a four-part article series on supply chains,…
Following the US administration’s’ extensive new import tariffs, many companies are grappling with increased costs and supply chain uncertainty. What happens when a deal becomes financially unsustainable due to government-imposed trade restrictions? Companies should consider the force majeure and change…
